经皮腔内球囊扩张血管成形术与血管支架植入术治疗下肢动脉硬化闭塞症的临床观察

doi:10.3969/j.issn.1001-8131.2023.04.007

Abstract
Figure/Table
References
Related Citation (1)

Download: PDF (443 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the clinical effect of percutaneous transluminal balloon angioplasty（PTA）and vascular stent implantation in patients with lower extremity arteriosclerosis obliterans（ASO）. Methods A total of 60 ASO patients treated in our hospital were selected and divided into two groups according to the random number table method,30 cases in each group.The control group was treated with PTA,and the observation group was treated with PTA and vascular stent implantation.The clinical efficacy,ankle/brachial index（ABI）,claudication distance,quality of life,complications and target lesion revascularization rate（TLR）were compared between the two groups. Results The postoperative health survey short form（SF-36）score of the observation group was higher than that of the control group,and the TLR was lower than that of the control group,with statistical differences（P<0.05）.There was no statistical difference in the total incidence（P>0.05）. Conclusion The treatment effect of PTA or PTA combined with vascular stent implantation in ASO patients is similar,but PTA combined with vascular stent implantation in ASO patients can reduce TLR and improve the quality of life of patients,which can be used as a more effective interventional operation for the treatment of ASO.

Key words： lower extremity arteriosclerosis obliterans percutaneous intraluminal balloon angioplasty vascular stent implantation target lesion revascularization rate

Received: 05 October 2022

PACS:

R543.1+2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Zhang Guobing

Cite this article:

Zhang Guobing. Clinical Observation of Percutaneous Intraluminal Balloon Angioplasty and Vascular Stent Implantation in the Treatment of Lower Extremity Arteriosclerosis Obliterans[J]. journal1, 2023, 43(4): 21-23.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2023.04.007 OR http://www.hrbyybjb.org.cn/EN/Y2023/V43/I4/21

[1] 李琳琳,李光新,王宾.保守与介入治疗Fontaine Ⅱ期下肢动脉硬化闭塞症患者近期和远期疗效对比[J].中华普通外科杂志,2021,36(12):931-935.
[2] 张坤,陈忠,胡忠洲,等.生物可降解血管支架在下肢动脉硬化闭塞症中的临床应用进展[J].中华外科杂志,2021,59(12):1032-1036.
[3] 马孝芬,刘乃全,高树熹,等.超声引导下经皮球囊扩张血管成形术治疗自体动静脉内瘘狭窄的自身对照研究[J].中国临床医学影像杂志,2021,32(8):561-564.
[4] 柏霞,潘力生,丁振.言语激励联合流程化健康宣教对下肢动脉硬化闭塞症患者负面情绪及生活质量的影响[J].西部中医药,2021,34(12):139-143.
[5] 陈洪让,李永生,张志功,等.云平台调查下肢动脉硬化闭塞症患者院外疼痛现状及影响因素分析[J].广东医学,2019,40(5):656-660.
[6] 李冈栉,赵瑾洁,马蓉,等.下肢动脉旁路移植术与腔内血管成形术治疗老年人下肢动脉硬化闭塞症的安全性和有效性探讨[J].中国普通外科杂志,2019,28(6):756-761.
[7] 卢庆威,王军,王刚,等.基于数据库数据分析下肢动脉硬化闭塞症患者腔内介入术治疗后支架内再狭窄的危险因素[J].山东医药,2020,60(30):80-83.
[8] 范卫东,郭兴友,张拓.DSA引导下血管腔内成形术治疗下肢动脉硬化闭塞症的临床研究[J].中国现代普通外科进展,2021,24(4):273-277.
[9] 徐永平,陈伟彬,陈俊卯,等.下肢动脉硬化闭塞症患者支架植入术后外周血单个核细胞中SIRT7水平变化及意义[J].山东医药,2020,60(31):73-75.
[10] 田珂,常超.经皮腔内血管成形术/支架植入术联合瑞舒伐他汀治疗下肢动脉硬化闭塞症远期疗效分析[J].中华实验外科杂志,2019,36(1):175-176.
[11] 徐超,余朝文,聂中林,等.自体大隐静脉搭桥与血管腔内支架植入在下肢动脉硬化闭塞症中的应用比较[J].广州医科大学学报,2019,47(6):22-24.
[12] 李全成,苏少飞,张忠梅.经皮腔内血管介入治疗老年下肢动脉硬化闭塞症的疗效及其影响因素分析[J].中华老年心脑血管病杂志,2019,21(11):1207-1208.